Eyenovia, Inc.
NASDAQ:EYEN
Overview | Financials
Company Name | Eyenovia, Inc. |
Symbol | EYEN |
Currency | USD |
Price | 0.494 |
Market Cap | 37,993,244 |
Dividend Yield | 0% |
52-week-range | 0.37 - 2.57 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Michael M. Rowe |
Website | https://www.eyenovia.com |
An error occurred while fetching data.
About Eyenovia, Inc.
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD